Tyrosine Kinase Inhibitors Market Sales Revenue Clinical Trials Pipeline Report 2015

Tyrosine kinase is a sub class of Protein Kinases family of enzyme responsible for phosphorylation.It has been found that mutation or other anomaly in these enzymes causes uncontrolled cell division leading to cancer. Because of their direct involvement in cell division they are used in cancer treatment by using kinase inhibitors to prevent unregulated cellular proliferation. Epidermal Growth Factor Receptor Family (EFGR) are present on the cell surface and anomalies like mutations leads to the cancer formation and its members have been found to have activity like receptor tyrosine kinases. EFGR Members of these families have been found to be overexpressed in various malignancies like breast cancer, glioblastoma and lung cancer. They are utilized for formulating targeted therapeutics for cancer treatment. Her1/ Her2 are commonly found to be overexpressed in case of breast cancer and many cancer therapeutics have been developed to treat metastatic condition.

Download Report:

https://www.kuickresearch.com/report-Tyrosine-Kinase-Inhibitors-Market-&-Pipeline-Insight-2015.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

"Tyrosine Kinase Inhibitors Market & Pipeline Insight 2015" Table of Contents

1. Introduction to Tyrosine Kinases Inhibitors

2. Mechanism of Tyrosine Kinase Therapeutics

3. Global Tyrosine Kinase Therapeutics Market Overview
3.1 Current Market Scenario
3.2 Tyrosine Kinase Inhibitors Pipeline Overview

4. Global Tyrosine Kinase Therapeutics Market Dynamics
4.1 Favorable Market Parameters
4.2 Market Challenges

5. Global Tyrosine Kinase Therapeutics Market Future Prospects

6. Global Tyrosine Kinase Inhibitors Pipeline by Company, Indication & Phase
6.1 Unknown
6.2 Research
6.3 Preclinical
6.4 Clinical
6.5 Phase-I
6.6 Phase-I/II
6.7 Phase-II
6.8 Phase-II/III
6.9 Phase-III
6.10 Preregistration
6.11 Registered

7. Marketed Tyrosine Kinase Inhibitors by Company & Indication

8. Suspended & No Development Reported Tyrosine Kinase Inhibitors Pipeline
8.1 No Development Reported
8.2 Discontinued
8.3 Market Withdrawal
8.4 Suspended

9. Competitive Landscape
9.1 Advenchen Laboratories
9.2 Array Pharmaceuticals
9.3 AstraZeneca
9.4 Bayer Healthcare Pharmaceuticals
9.5 Biogen Idec
9.6 Bristol-Myer Squibb
9.7 Boehringer Ingelheim
9.8 Chugai Pharmaceutical
9.9 Celgene Corporation
9.10 Exelixis
9.11 Incyte Corporation
9.12 GalaxoSmithKline
9.13 Johnson & Johnson
9.14 Merck
9.15 Novartis
9.16 Onyx pharmaceuticals
9.17 Pfizer
9.18 Sanofi
9.19 Tolero Pharmaceutical
9.20 QIAGEN

Figure 1-1: Flow Chart of Phosphorylation
Figure 1-2: Hierarchy of EFGR Family
Figure 1-3: Hierarchy of VEGFR Family
Figure 1-4: Features of Receptor Tyrosine Kinase
Figure 1-5: Benefits of Tyrosine Kinase Inhibitors
Figure 2-1: Properties of Tyrosine Kinase Therapeutics
Figure 2-2: Mechanism of Nexavar
Figure 2-3: Mechanism of Gleevac
Figure 2-4: Mechanism of Tyverb
Figure 2-5: Benefits of Monoclonal Antibodies
Figure 2-6: Mechanism of Avastin
Figure 2-7: Mechanism of Rituximab
Figure 3-1: Tyrosine Kinase Inhibitors Pipeline by Phase (%), 2015
Figure 3-2: Tyrosine Kinase Inhibitors Pipeline by Phase (Numbers), 2015
Figure 3-3: No Development Reported in Tyrosine Kinase Inhibitors Pipeline by Phase (%), 2015
Figure 3-4: No Development Reported in Tyrosine Kinase Inhibitors Pipeline by Phase (Number), 2015
Figure 3-5: Discontinued Tyrosine Kinase Inhibitors Pipeline by Phase (%), 2015
Figure 3-6: Discontinued Tyrosine Kinase Inhibitors Pipeline by Phase (Number), 2015
Figure 3-7: Suspended Tyrosine Kinase Inhibitors Pipeline by Phase (%), 2015
Figure 3-8: Suspended Tyrosine Kinase Inhibitors Pipeline by Phase (Number), 2015
Figure 4-1: Tyrosine Kinase Therapeutics Favorable Market Parameters

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.